{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:05:06Z","timestamp":1791421506405,"version":"4.3.3"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejmech.2021.114064","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:37:08Z","timestamp":1640947028000},"page":"114064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4653","authenticated-orcid":false,"given":"Jimin","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Mazraani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-6339","authenticated-orcid":false,"given":"Matthew J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5440-8771","authenticated-orcid":false,"given":"Allan B.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-1287","authenticated-orcid":false,"given":"Wilhelmina M.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0783-1635","authenticated-orcid":false,"given":"Joel D.A.","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114064_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.ejmech.2021.114064_bib2","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.114064_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40588-014-0005-8","article-title":"Chronic chlamydial diseases: from atherosclerosis to urogenital infections","volume":"1","author":"Leonard","year":"2014","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"10.1016\/j.ejmech.2021.114064_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/IDR.S105469","article-title":"Mycoplasma genitalium infections: current treatment options and resistance issues","volume":"10","author":"Sethi","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2021.114064_bib5","doi-asserted-by":"crossref","first-page":"105911","DOI":"10.1016\/j.ijantimicag.2020.105911","article-title":"Molecular basis of antimicrobial resistance in Mycoplasma genitalium","volume":"55","author":"van der Schalk","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2021.114064_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bjm.2017.06.001","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat","volume":"48","author":"Costa-Lourenco","year":"2017","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.ejmech.2021.114064_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13756-020-00805-7","article-title":"Azithromycin resistant gonococci: a literature review","volume":"9","author":"Derbie","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.ejmech.2021.114064_bib8","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2666-5247(20)30059-8","article-title":"Antimicrobial-Resistant Neisseria gonorrhoeae Working Group, Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance data","volume":"1","author":"Gernert","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejmech.2021.114064_bib9","unstructured":"Australian Government; Department of Agriculture Water and the Environment, Phascolarctos cinereus (Combined Populations of Qld, NSW and the ACT) \u2014 Koala (Combined Populations of Queensland, New South Wales and the Australian Capital Territory)."},{"key":"10.1016\/j.ejmech.2021.114064_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biocon.2015.09.020","article-title":"Conserving koalas: a review of the contrasting regional trends, outlooks and policy challenges","volume":"192","author":"McAlpine","year":"2015","journal-title":"Biol. Conserv."},{"key":"10.1016\/j.ejmech.2021.114064_bib11","series-title":"Koala Extinction Risk NSW","author":"Taylor","year":"2018"},{"key":"10.1016\/j.ejmech.2021.114064_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1751-0813.1990.tb07805.x","article-title":"Use of a dietary supplement in koalas during systemic antibiotic treatment of chlamydial infection","volume":"67","author":"Osawa","year":"1990","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.ejmech.2021.114064_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1039\/C7MD00528H","article-title":"Narrow-spectrum antibacterial agents","volume":"9","author":"Melander","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2021.114064_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10096-014-2075-1","article-title":"Bacterial proteases: targets for diagnostics and therapy","volume":"33","author":"Kaman","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.114064_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092232","article-title":"ClpP protease, a promising antimicrobial target","volume":"20","author":"Moreno-Cinos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.114064_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/fmb.13.25","article-title":"Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets","volume":"8","author":"Roberts","year":"2013","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ejmech.2021.114064_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00253-011-3834-x","article-title":"Microbial and fungal protease inhibitors\u2013current and potential applications","volume":"93","author":"Sabotic","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.114064_bib18","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2174\/0929867323666161223145825","article-title":"The extracellular bacterial HtrA proteins as potential therapeutic targets and vaccine candidates","volume":"24","author":"Skorko-Glonek","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12845","article-title":"Extracellular HtrA serine proteases: an emerging new strategy in bacterial pathogenesis","volume":"20","author":"Backert","year":"2018","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ejmech.2021.114064_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-017-0162-5","article-title":"Bacterial serine protease HtrA as a promising new target for antimicrobial therapy?","volume":"15","author":"Wessler","year":"2017","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2021.114064_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cmi.2020.12.017","article-title":"HtrA family proteases of bacterial pathogens: pros and cons for their therapeutic use","volume":"27","author":"Xue","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2021.114064_bib22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA proteases: regulated proteolysis in protein quality control","volume":"12","author":"Clausen","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.114064_bib23","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1074\/jbc.RA119.007387","article-title":"The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping","volume":"294","author":"Zhang","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/minf.201100147","article-title":"From virtual screening to bioactive compounds by visualizing and clustering of chemical space","volume":"31","author":"Klenner","year":"2012","journal-title":"Mol Inform"},{"key":"10.1016\/j.ejmech.2021.114064_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017986","article-title":"Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epithelia","volume":"6","author":"Lower","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.114064_bib26","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1039\/C4SC01443J","article-title":"Inhibiting Helicobacter pylori HtrA protease by addressing a computationally predicted allosteric ligand binding site","volume":"5","author":"Perna","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2021.114064_bib27","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1002\/anie.201504035","article-title":"Fragment-based de novo design reveals a small-molecule inhibitor of Helicobacter pylori HtrA","volume":"54","author":"Perna","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2021.114064_bib28","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/cmdc.201900193","article-title":"Chemical validation of DegS as a target for the development of antibiotics with a novel mode of action","volume":"14","author":"Bongard","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.114064_bib29","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/acschembio.0c00279","article-title":"Activity-based probes for the high temperature requirement A serine proteases","volume":"15","author":"Nam","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.114064_bib30","doi-asserted-by":"crossref","first-page":"50295","DOI":"10.1074\/jbc.M406006200","article-title":"Regulation of HAX-1 anti-apoptotic protein by Omi\/HtrA2 protease during cell death","volume":"279","author":"Cilenti","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib31","series-title":"Carbocyclic Prolinamide Derivatives","author":"Gomez","year":"2017"},{"key":"10.1016\/j.ejmech.2021.114064_bib32","series-title":"Heterocyclic Prolinamide Derivatives","author":"Gomez","year":"2017"},{"key":"10.1016\/j.ejmech.2021.114064_bib33","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.0501823102","article-title":"Implications of the serine protease HtrA1 in amyloid precursor protein processing","volume":"102","author":"Grau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.114064_bib34","series-title":"New Trifluoromethyl Propanamide Derivatives as HtrA1 Inhibitors","author":"Hornsperger","year":"2018"},{"key":"10.1016\/j.ejmech.2021.114064_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1039\/C9NP00033J","article-title":"From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides","volume":"37","author":"Kocher","year":"2020","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.114064_bib36","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1002\/anie.201701771","article-title":"Tailored ahp-cyclodepsipeptides as potent non-covalent serine protease inhibitors","volume":"56","author":"Kocher","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2021.114064_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/mmi.12306","article-title":"Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis","volume":"89","author":"Gloeckl","year":"2013","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2021.114064_bib38","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.bmc.2019.07.049","article-title":"Structure-activity analysis of peptidic Chlamydia HtrA inhibitors","volume":"27","author":"Agbowuro","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib39","doi-asserted-by":"crossref","first-page":"113692","DOI":"10.1016\/j.ejmech.2021.113692","article-title":"Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues","volume":"224","author":"Hwang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib40","doi-asserted-by":"crossref","first-page":"10807","DOI":"10.1021\/acs.jmedchem.6b00319","article-title":"Unusual amino acids in medicinal chemistry","volume":"59","author":"Blaskovich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib41","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1021\/ja3109664","article-title":"Proline editing: a general and practical approach to the synthesis of functionally and structurally diverse peptides. Analysis of steric versus stereoelectronic effects of 4-substituted prolines on conformation within peptides","volume":"135","author":"Pandey","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114064_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9459(24)03854-3","article-title":"Medicinal chemistry and therapeutic relevance of angiotensin-converting enzyme inhibitors","volume":"71","author":"Alsharif","year":"2007","journal-title":"Am. J. Pharmaceut. Educ."},{"key":"10.1016\/j.ejmech.2021.114064_bib43","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/med.21475","article-title":"Proteases and protease inhibitors in infectious diseases","volume":"38","author":"Agbowuro","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.114064_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.114064_bib45","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1002\/asia.201100432","article-title":"Click chemistry: 1,2,3-triazoles as pharmacophores","volume":"6","author":"Agalave","year":"2011","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.ejmech.2021.114064_bib46","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1021\/jm2003624","article-title":"Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain","volume":"54","author":"Boechat","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib47","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.bmc.2019.07.005","article-title":"1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: a recent overview","volume":"27","author":"Bozorov","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib48","doi-asserted-by":"crossref","first-page":"127746","DOI":"10.1016\/j.bmcl.2020.127746","article-title":"1,2,3-triazole-thiazole hybrids: synthesis, in\u00a0vitro antimicrobial activity and antibiofilm studies","volume":"33","author":"Gondru","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.114064_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13065-020-00717-y","article-title":"Synthesis and biological evaluation of heterocyclic 1,2,4-triazole scaffolds as promising pharmacological agents","volume":"15","author":"Kumari","year":"2021","journal-title":"BMC Chem"},{"key":"10.1016\/j.ejmech.2021.114064_bib50","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1039\/C9RA09510A","article-title":"CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review","volume":"10","author":"Rani","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.114064_bib51","series-title":"1,2,4-Triazoles as Important Antibacterial Agents","author":"Strzelecka","year":"2021"},{"key":"10.1016\/j.ejmech.2021.114064_bib52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmech.2019.02.055","article-title":"Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids","volume":"168","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib54","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.tet.2017.10.031","article-title":"Stereochemical basis for the anti-chlamydial activity of the phosphonate protease inhibitor JO146","volume":"74","author":"Agbowuro","year":"2017","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.114064_bib55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/tx015574b","article-title":"Biotransformation reactions of five-membered aromatic heterocyclic rings","volume":"15","author":"Dalvie","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2021.114064_bib56","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1021\/ja0450408","article-title":"Heterocyclic peptide backbone modifications in an alpha-helical coiled coil","volume":"126","author":"Horne","year":"2004","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114064_bib57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1039\/C5QO00016E","article-title":"The Mitsunobu reaction in the 21st century","volume":"2","author":"Flethcher","year":"2015","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2021.114064_bib58","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1016\/j.febslet.2007.06.039","article-title":"The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 degrees C","volume":"581","author":"Huston","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2021.114064_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024547","article-title":"Unique residues involved in activation of the multitasking protease\/chaperone HtrA from Chlamydia trachomatis","volume":"6","author":"Huston","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2021.114064_bib60","doi-asserted-by":"crossref","first-page":"10490","DOI":"10.1073\/pnas.1101084108","article-title":"The Legionella HtrA homologue DegQ is a self-compartmentizing protease that forms large 12-meric assemblies","volume":"108","author":"Wrase","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.114064_bib61","doi-asserted-by":"crossref","first-page":"31466","DOI":"10.1038\/srep31466","article-title":"Chlamydia serine protease inhibitor, targeting HtrA, as a new treatment for koala Chlamydia infection","volume":"6","author":"Lawrence","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.114064_bib62","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.114064_bib63","first-page":"3919","article-title":"The antimicrobial peptides and their potential clinical applications","volume":"11","author":"Lei","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ejmech.2021.114064_bib64","doi-asserted-by":"crossref","first-page":"15997","DOI":"10.1073\/pnas.0606129103","article-title":"Ultrashort antibacterial and antifungal lipopeptides","volume":"103","author":"Makovitzki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.114064_bib65","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1021\/bi701929m","article-title":"Structure and function of the virulence-associated high-temperature requirement A of Mycobacterium tuberculosis","volume":"47","author":"Mohamedmohaideen","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.114064_bib66","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nsmb.1840","article-title":"HtrA proteases have a conserved activation mechanism that can be triggered by distinct molecular cues","volume":"17","author":"Krojer","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.114064_bib67","first-page":"10","article-title":"The active site residue V266 of Chlamydial HtrA is critical for substrate binding during both in\u00a0vitro and in\u00a0vivo conditions","volume":"22","author":"Gloeckl","year":"2012","journal-title":"J.\u00a0Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejmech.2021.114064_bib68","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2478\/s11658-013-0103-2","article-title":"Proteolytic activation of Chlamydia trachomatis HTRA is mediated by PDZ1 domain interactions with protease domain loops L3 and LC and beta strand beta5","volume":"18","author":"Marsh","year":"2013","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2021.114064_bib69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/ja005542v","article-title":"Conformational stability of collagen relies on a stereoelectronic effect","volume":"123","author":"Bretscher","year":"2001","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114064_bib70","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.1021\/ja9623119","article-title":"Inductive effects on the energetics of prolyl peptide bond isomerization: implications for collagen folding and stability","volume":"118","author":"Eberhardt","year":"1996","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114064_bib71","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1039\/c2ob06720j","article-title":"Conformational stability of collagen triple helices functionalized in the Yaa position by click chemistry","volume":"10","author":"Erdmann","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib72","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1021\/ja0749993","article-title":"Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism","volume":"130","author":"Boren","year":"2008","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114064_bib73","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"Consortium","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.114064_bib74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jmbi.2000.4042","article-title":"T-Coffee: a novel method for fast and accurate multiple sequence alignment","volume":"302","author":"Notredame","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2021.114064_bib75","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1110\/ps.062416606","article-title":"Statistical potential for assessment and prediction of protein structures","volume":"15","author":"Shen","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2021.114064_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2021.114064_bib77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/jm00001a015","article-title":"Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and X-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketones","volume":"38","author":"Veale","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114064_bib78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/1471-2334-13-379","article-title":"A\u00a0cohort study of Chlamydia trachomatis treatment failure in women: a study protocol","volume":"13","author":"Hocking","year":"2013","journal-title":"BMC Infect. Dis."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421009132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421009132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:34:57Z","timestamp":1759329297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421009132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":78,"alternative-id":["S0223523421009132"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114064","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2021-3nm6w","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114064"}}